Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk

Williams SG, Duchesne GM, Gogna NK, Millar JL, Pickles T, Pratt GR, Turner S

(2006), Int J Radiat Oncol Biol Phys, 65(2), 351-7

Management of glioma in Victoria (1998-2000): retrospective cohort study

Rosenthal MA, Drummond KJ, Dally M, Murphy M, Cher L, Ashley D, Thursfield V, Giles GG

(2006), Med J Aust, 184(6), 270-3

Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?

Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L

(2006), Int J Radiat Oncol Biol Phys, 64(1), 114-9

Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma

Ng M, Wirth A, Ryan G, MacManus M, Davis S

(2006), Australas Radiol, 50(3), 222-7

Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective

Newton FJ, Burney S, Millar JL, Frydenberg M, Ng KT

(2006), BJU Int, 97(6), 1179-83

Alternative explanations for T-cell response to in-situ gene therapy for prostate cancer: in reply to Fujita et al. (Int J Radiat Oncol Biol Phys 2006;65:84-90)

Millar JL, Sutherland JS, Boyd RL.

(2006), Int J Radiat Oncol Biol Phys, 66(5), 1599

Management of muscle-invasive bladder cancer in Victoria, 1990-1995

Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG; Urology Study Committee of the Victorian Co-operative Oncology Group

(2006), ANZ J Surg, 76(3), 113-9

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, Johnson C, Spry N; Trans Tasman Radiation Oncology Group

(2006), Radiother Oncol, 81(2), 136-42

Several acidic amino acids in the N-domain of insulin-like growth factor-binding protein-5 are important for its transactivation activity

Zhao Y, Yin P, Bach LA, Duan C

(2006), J Biol Chem, 281(20), 14184-91

Clinical case review. Hyperthyroidism in an 84-year-old patient with cardiovascular disease

Topliss DJ

(2006), Med Today, 7(6), 71-72

Clinical case review. De Quervain’s thyroiditis and papillary thyroid carcinoma in a 39-year-old woman

Topliss DJ

(2006), Med Today, 7(10), 63-64

Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study

Li M, Eastman CJ, Waite KV, Ma G, Zacharin MR, Topliss DJ, Harding PE, Walsh JP, Ward LC, Mortimer RH, Mackenzie EJ, Byth K, Doyle Z

(2006), Med J Aust, 184(4), 165-9

Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2)

Kuang Z, Yao S, Keizer DW, Wang CC, Bach LA, Forbes BE, Wallace JC, Norton RS

(2006), J Mol Biol, 364(4), 690-704

A cool case: hypothermia and adrenal failure

Grossmann M, Topliss DJ

(2006), Lancet, 368(9553), 2184

Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner

Gallicchio MA, McRobert EA, Tikoo A, Cooper ME, Bach LA

(2006), J Am Soc Nephrol, 17(2), 414-21

Effect of ramipril on the incidence of diabetes

DREAM Trial Investigators; Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR

(2006), N Engl J Med, 355(15), 1551-62

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators; Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR

(2006), Lancet, 368(9541), 1096-105

Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93

Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS; International Breast Cancer Study Group

(2006), Clin Oncol, 24(3), 337-44

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays

Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurkula M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B; International Breast Cancer Study*

(2006), J Natl Cancer Inst, 98(21), 1571-81

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, Simoncini E, Castiglione-Gertsch M, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group (IBCSG).

(2006), Ann Oncol, 17(6), 935-44

749 750 751 752 753